Advertisement

Topics

Seikagaku Corporation Japan Company Profile

15:59 EST 21st November 2017 | BioPortfolio

Arthritis Therapies

Location

1-5 Nihonbashi Hon-cho 2-chome, Chuo-ku
Tokyo
Tokyo
103
Japan

Contact

Phone: 81 3 3270 0966
Fax: 81 3 3270 0538


News Articles [282 Associated News Articles listed on BioPortfolio]

Seikagaku grants Ono rights to co-develop and market SI-613 in Japan

CombiMatrix Corporation Stockholders Approve Merger Agreement With Invitae Corporation

IRVINE, Calif., Nov. 10, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based r...

CombiMatrix Corporation Reminds Shareholders to Vote "FOR" the Merger With Invitae Corporation

IRVINE, Calif., Nov. 02, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based r...

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend CombiMatrix Corporation Shareholders Vote "FOR" the Proposed Merger with Invitae Corporation

IRVINE, Calif., Nov. 01, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based r...

Global and Asia Hydrogel Market Status and Future Forecast 20132023 [Report Updated: 16102017] Prices from USD $3000

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPar...

All Japanese osteoarthritis deal could total 12 billion yen

Ono Pharmaceutical and Seikagaku Corporation have announced a deal for a co-development and marketing…

Orion Corporation: Managers' transactions - Hilpi Rautelin

ORION CORPORATION      MANAGERS' TRANSACTIONS 1st of November 2017 at 22.15 EET              Orion Corporation: Managers' transactions - Hilpi Rautelin Orion Cor...

Seikagaku Corp 4548 Financial and Strategic SWOT Analysis Review [Report Updated: 07082017] Prices from USD $300

SummarySeikagaku Corp Seikagaku is a medical device company that develops and provides pharmaceuticals in the field of glycoscience. The company offers products such as pharmaceuticals and medical dev...

PubMed Articles [453 Associated PubMed Articles listed on BioPortfolio]

Cumulative incidence of Kawasaki disease in Japan.

Although the nationwide surveys of Kawasaki disease (KD) in Japan have revealed the incidence rates of KD in this country, cumulative incidences, e.g., the proportion of those with a history of KD amo...

First progress report on the Japan Endoscopy Database (JED) project.

The Japan Endoscopy Database (JED) Project was initiated to develop the world's largest endoscopic database, capture the actual performance of endoscopic practice, and standardize the terminology and ...

Trend and treatment status of latent tuberculosis infection patients in Japan - Analysis of Japan TB Surveillance data.

Management of latent tuberculosis infection (LTBI) is one of the core elements of End TB Strategy. Japan is one of the few countries in which notification of LTBI is mandatory, yet so far, the data ha...

Japan Prize/Special Award in Synthetic Organic Chemistry, Japan/CNRS Medals.

Current status of portal vein thrombosis in Japan: Results of a questionnaire survey by the Japan Society for Portal Hypertension.

To investigate the current status of portal vein thrombosis (PVT) in Japan, the Clinical Research Committee of the Japan Society of Portal Hypertension conducted a questionnaire survey.

Clinical Trials [317 Associated Clinical Trials listed on BioPortfolio]

Clinical Characteristics and Practice Patterns of T2DM Patients Treated With OADs in Japan: Analysis of Medical and Health Care Database of the MDV

Appropriate use of oral antidiabetic drugs (OADs) including dose-reduction is important for patient's safety in T2DM patients with renal impairment (RI). However, there are insufficient da...

GLP-1 Agonist AVE0010 in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy (GETGOAL-MONO Japan LTS)

The purpose of this study is to evaluate the safety and tolerability of AVE0010 once daily treatment in monotherapy in type 2 diabetes patients in Japan over 76 weeks of treatment. The pr...

A Study to Observe the Treatment Patterns and Outcomes of Patients in Japan With Kidney Cancer That is Unable to be Removed by Surgery or That Has Spread

A medical review chart study in Japan to describe the treatment patterns and outcomes of patients with kidney cancer that is unable to be removed by surgery or that has spread. The clinica...

Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-ACS)

The purpose of this study is to compare the effects of pitavastatin and atorvastatin on coronary plaque volume in patients with acute coronary syndrome and to clarify the relationship betw...

PROMUS Element Japan Small Vessel Trial

A non-randomized, small vessel (SV) trial at approximately 15 sites in Japan to enroll 60 patients with a de novo lesion ≤28 mm in length (by visual estimate) in a native coronary arte...

Companies [582 Associated Companies listed on BioPortfolio]

Seikagaku America Incorporated

Seikagaku America is the US subsidiary of Seikagaku Corporation...The Pioneer of Glycoscience! We are a primary supplier of unique and high quality research biochemicals for Carbohydrate Chemistry, Mo...

Seikagaku Corporation Japan

Arthritis Therapies

Seikagaku Corporation

Nil

S.T.Japan-USA, LLC

S.T. Japan USA, LLC is the American branch of S.T. Japan, Inc. . It is a member of the S.T. Japan Group. Our main functions and activities are:To directly sell to End-Users located in the USA and the ...

TOSHIBA TEC CORPORATION

TOSHIBA TEC CORPORATION is engaged in digital product business of the TOSHIBA group. Expanding its operation for the whole world, the range of products is formed by POS ...

More Information about "Seikagaku Corporation Japan" on BioPortfolio

We have published hundreds of Seikagaku Corporation Japan news stories on BioPortfolio along with dozens of Seikagaku Corporation Japan Clinical Trials and PubMed Articles about Seikagaku Corporation Japan for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Seikagaku Corporation Japan Companies in our database. You can also find out about relevant Seikagaku Corporation Japan Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Gout
According to the National Arthritis Data Workgroup, an estimated 6 million people in the United States report having experienced gout at some point in their lives. In fact, gout is the most common form of inflammatory arthritis in men over the age of 40....


Corporate Database Quicklinks



Searches Linking to this Company Record